Do not try this at home: patterns and outcomes of radiation dose de-escalation in p16-positive oropharyngeal carcinoma
Asher J. Shin, Ethan D. Shin, Victor Lee, Edward Christopher Dee, Sean McBride, Yao Yu, Nadeem Riaz, Jung Julie Kang · 2026
Read Do not try this at home: patterns and outcomes of radiation dose de-escalation in p16-positive oropharyngeal carcinoma by Asher J. Shin, Ethan D. Shin, Victor Lee, Edward Christopher Dee, Sean McBride, Yao Yu, Nadeem Riaz, Jung Julie Kang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13590389.txt.
Description
Asher Shin and co-authors study lower radiation doses for a throat cancer tied to a common virus. Their 2026 study asks how often clinics in the United States cut doses in real practice, and how patients fare. Trial failures had left real-world uptake and outcomes unclear.
A national cancer database gave close to fifteen thousand patients treated from 2018 to 2022 with radiation alone as main therapy. About one in thirteen got the lower dose range, more often at academic centers. Three-year survival was lower in the lower-dose group than in the standard-dose group. The gap held for patients who also got chemotherapy. The authors warn against dose cuts outside trials, since survival suffered in routine care.
Catalog record
| CREATOR | Asher J. Shin, Ethan D. Shin, Victor Lee, Edward Christopher Dee, Sean McBride, Yao Yu, Nadeem Riaz, Jung Julie Kang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |